Do endothelial progenitor cells modify our strategy to treat risk factors?

Do endothelial progenitor cells modify our strategy to treat risk factors?

Show other versions (1)

Detalles Bibliográficos
Main Authors:	Tousoulis, D, Andreou, I, Antoniades, C, Siasos, G, Stougiannos, P, Trikas, A, Stefanadis, C
Formato:	Journal article
Idioma:	English
Publicado:	2011

Títulos similares

Do endothelial progenitor cells modify our strategy to treat risk factors?
por: Tousoulis, D, et al.
Publicado: (2010)

Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
por: Andreou, I, et al.
Publicado: (2006)

Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
por: Tousoulis, D, et al.
Publicado: (2008)

Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
por: Bakogiannis, C, et al.
Publicado: (2012)

The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
por: Briasoulis, A, et al.
Publicado: (2011)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
por: Gounari, P, et al.
Publicado: (2010)

C-reactive protein and endothelial dysfunction: Gazing at the coronaries
por: Tousoulis, D, et al.
Publicado: (2011)

C-reactive protein and endothelial dysfunction: gazing at the coronaries.
por: Tousoulis, D, et al.
Publicado: (2011)

Endothelial dysfunction: potential clinical implications.
por: Tousoulis, D, et al.
Publicado: (2010)

Progenitor cells and vascular endothelium
por: Briasoulis, A, et al.
Publicado: (2011)

Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
por: Tentolouris, C, et al.
Publicado: (2004)

Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
por: Tousoulis, D, et al.
Publicado: (2005)

Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals.
por: Siasos, G, et al.
Publicado: (2008)

Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques.
por: Tousoulis, D, et al.
Publicado: (2005)

Beneficial effects of statin treatment after myocardial infarction: Is progenitor cell mobilization the missing link?
por: Tousoulis, D, et al.
Publicado: (2008)

Cold pressor test as a marker for the detection of early stage coronary atherosclerosis.
por: Tousoulis, D, et al.
Publicado: (2007)

02.02 SHORT-TERM DAILY ADMINISTRATION OF L-ARGININE IMPROVES ENDOTHELIAL FUNCTION AND ARTERIAL STIFFNESS IN HEALTHY SMOKERS
por: G. Siasos*, et al.
Publicado: (2007-06-01)

Effects of endothelial nitric oxide synthase gene polymorphisms on oxidative stress, inflammatory status, and coronary atherosclerosis: an example of a transient phenotype.
por: Antoniades, C, et al.
Publicado: (2007)

Biomarkers of premature atherosclerosis.
por: Kampoli, A, et al.
Publicado: (2009)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
por: Siasos, G, et al.
Publicado: (2007)

Evaluation of endothelial function
por: Antoniades, C, et al.
Publicado: (2011)

The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance.
por: Siasos, G, et al.
Publicado: (2009)

Red wine and vascular endothelium
por: Tousoulis, D, et al.
Publicado: (2009)

Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
por: Tousoulis, D, et al.
Publicado: (2007)

Methionine-loading rapidly impairs endothelial function, by mechanisms independent of endothelin-1: evidence for an association of fasting total homocysteine with plasma endothelin-1 levels.
por: Tousoulis, D, et al.
Publicado: (2008)

Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels.
por: Tousoulis, D, et al.
Publicado: (2009)

Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
por: Antoniades, C, et al.
Publicado: (2007)

Left atrial function, cytokines and soluble apoptotic markers in mitral stenosis: effects of valvular replacement.
por: Trikas, A, et al.
Publicado: (2005)

Homocysteine: a risk factor for coronary artery disease?
por: Marinou, K, et al.
Publicado: (2005)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
por: Tousoulis, D, et al.
Publicado: (2010)

Gene therapy for dysfunctional endothelium: is dimethylarginine dimethylaminohydrolase-2 a therapeutic target?
por: Tousoulis, D, et al.
Publicado: (2010)

Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure.
por: Trikas, A, et al.
Publicado: (2006)

Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction.
por: Antonopoulos, A, et al.
Publicado: (2013)

Genetic variability on adiponectin gene affects myocardial infarction risk: The role of endothelial dysfunction
por: Antonopoulos, A, et al.
Publicado: (2013)

Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
por: Demosthenous, M, et al.
Publicado: (2011)

Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
por: Demosthenous, M, et al.
Publicado: (2011)

New biochemical markers in acute coronary syndromes.
por: Tousoulis, D, et al.
Publicado: (2008)

Circulating biomarkers for the diagnosis and prognosis of heart failure.
por: Tousoulis, D, et al.
Publicado: (2009)

From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.
por: Tousoulis, D, et al.
Publicado: (2010)

Combined effects of smoking and interleukin-6 and C-reactive protein genetic variants on endothelial function, inflammation, thrombosis and incidence of coronary artery disease
por: Hatzis, G, et al.
Publicado: (2014)